Most people think of PCOS as a reproductive condition. Irregular periods, acne, unwanted hair growth, difficulty getting pregnant. But at its core, Polycystic Ovary Syndrome is a metabolic disorder with reproductive consequences. The link between PCOS and insulin resistance explains many of its otherwise confusing symptoms and points to the most effective treatment approach.
India has one of the highest PCOS prevalence rates globally. Studies suggest 20 to 25 percent of Indian women of reproductive age have PCOS, compared to 6 to 12 percent globally. This is not just a cosmetic or fertility issue. PCOS is associated with a three to seven fold increased lifetime risk of Type 2 diabetes, and elevated risk of cardiovascular disease, endometrial cancer, and mental health conditions.
What is PCOS, exactly?
The Rotterdam criteria, the most widely used diagnostic framework, requires 2 of 3 features to diagnose PCOS:
- Irregular or absent ovulation, typically showing as fewer than 9 periods per year
- Clinical or biochemical hyperandrogenism, meaning elevated male hormones shown either by symptoms like acne and facial or body hair growth, or by elevated testosterone or DHEAS on blood tests
- Polycystic ovaries on ultrasound, meaning 12 or more follicles per ovary or ovarian volume greater than 10 ml
Note that polycystic ovaries alone does not equal PCOS. Many women have polycystic ovaries without the syndrome. The diagnosis requires the hormonal or menstrual features as well.
Why insulin resistance matters
Insulin is a hormone made by the pancreas that helps cells take up glucose from the bloodstream. Insulin resistance means cells do not respond normally to insulin, so the pancreas produces more and more insulin to achieve the same effect. This elevated circulating insulin is called hyperinsulinemia.
In women with PCOS, 70 to 80 percent have some degree of insulin resistance, even at normal body weight. This is one of the most distinctive features of PCOS and explains many symptoms that seem unrelated to the ovaries.
The insulin androgen connection
High circulating insulin directly stimulates the ovaries to produce more androgens, male hormones like testosterone. Insulin also reduces the liver production of sex hormone binding globulin, the protein that binds testosterone and keeps it inactive. Less binding globulin means more free active testosterone.
This double mechanism drives most PCOS symptoms:
- Acne: Excess androgens stimulate sebum production and inflammation in pilosebaceous units.
- Hirsutism: Male pattern hair growth on face, chest, and abdomen from androgen effects on hair follicles.
- Irregular periods: Excess androgens disrupt follicle selection and ovulation.
- Weight gain especially around the abdomen: Insulin resistance promotes fat storage in visceral depots.
- Hair thinning at the scalp crown: Androgenic pattern hair loss from elevated testosterone in susceptible individuals.
- Darkened skin patches (acanthosis nigricans): Classic sign of insulin resistance, typically at the neck, underarms, or groin.
How insulin resistance is tested
Several tests can identify insulin resistance. No single test is perfect. Most Indian endocrinologists use a combination.
Fasting insulin and HOMA-IR
Fasting insulin above 10 micro IU per ml is often considered elevated. HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is calculated from fasting glucose and fasting insulin. A HOMA-IR above 2.5 suggests insulin resistance. Above 3.5 is clearly abnormal.
HbA1c
Usually normal in early insulin resistance because the pancreas compensates. An elevated HbA1c in PCOS indicates advanced metabolic dysfunction, already approaching prediabetes.
Oral glucose tolerance test
The gold standard for insulin resistance detection. A 75 gram glucose load is administered after overnight fast, with glucose measured at 0, 1, and 2 hours. Elevated post load insulin with normal glucose suggests compensated insulin resistance. This test is underused in India because it takes 2 hours.
Lipid profile
Indirect marker. Women with insulin resistance typically have elevated triglycerides, low HDL cholesterol, and increased small dense LDL particles. A triglyceride to HDL ratio above 3 suggests metabolic syndrome.
Treatment approach for PCOS with insulin resistance
The evidence based approach to PCOS works through the insulin resistance pathway. Directly targeting insulin resistance often resolves many symptoms that seem unrelated.
Lifestyle modification (always first line)
A 5 to 10 percent body weight loss can restore ovulation in 50 to 70 percent of overweight women with PCOS. This is one of the most powerful interventions in reproductive medicine. Even without significant weight loss, improved body composition (more muscle, less abdominal fat) improves insulin sensitivity.
Dietary approach: Lower glycemic load diets, Mediterranean style eating, and adequate protein distribution across meals all help. Complete elimination of carbohydrates is not necessary and often unsustainable. Focus on whole grains over refined grains, include protein at every meal, and limit added sugars.
Exercise: Combined aerobic and resistance training produces the best improvements in insulin sensitivity. A minimum of 150 minutes per week of moderate intensity exercise is the standard recommendation. Resistance training twice per week adds independent benefit.
Metformin
Metformin is the most studied medication for PCOS related insulin resistance. It reduces liver glucose production, improves peripheral insulin sensitivity, and can help restore ovulation. Standard dose is 500 to 2000 mg daily in divided doses, started low and titrated up to minimize GI side effects. Metformin is often continued for 6 to 12 months minimum to see full metabolic benefit.
Inositol supplementation
Myo inositol and D chiro inositol have growing evidence in PCOS. A 40 to 1 ratio of myo to D chiro inositol, typically 4 grams per day total, has shown improvements in insulin sensitivity, ovulation rates, and pregnancy outcomes in multiple randomized trials. Inositol is well tolerated and can be used alongside metformin.
GLP-1 receptor agonists
Semaglutide and liraglutide are showing increasing use in PCOS, particularly for patients with significant insulin resistance and weight management challenges. In 2026, this is still an off label use in most countries for pure PCOS without diabetes or obesity comorbidity, but evidence is accumulating rapidly.
Hormonal contraceptives
Combined oral contraceptives are a mainstay for symptom management, particularly for acne, hirsutism, and period regularity. They do not treat insulin resistance but can dramatically improve quality of life while other interventions take effect. Pills containing anti androgenic progestins like drospirenone or cyproterone acetate are preferred for PCOS.
Anti androgens
Spironolactone 50 to 200 mg daily is effective for acne and hirsutism in women not trying to conceive. It takes 3 to 6 months to see effect. Spironolactone must be paired with reliable contraception in sexually active women because it can feminize a male fetus if used during pregnancy.
Fertility considerations
PCOS is the most common cause of ovulatory infertility. First line fertility treatment is ovulation induction with letrozole, which has superseded clomiphene in most guidelines. Metformin is added if there is insulin resistance or clomiphene resistance.
Important: Weight loss of 5 to 10 percent before fertility treatment significantly improves response rates and pregnancy outcomes. For women with BMI above 30, this is often the highest yield initial intervention.
Long term management
PCOS is a lifelong condition. Symptoms and priorities change across decades.
- Teens and 20s: Focus on acne, hirsutism, menstrual regularity, education about the condition
- 30s: Fertility, lifestyle management, weight, screening for metabolic risk
- 40s and beyond: Prevention of Type 2 diabetes, cardiovascular risk management, endometrial protection
Annual screening should include fasting glucose, HbA1c, lipid profile, blood pressure, and weight tracking. Endometrial protection requires at least 3 to 4 withdrawal bleeds per year, either through pregnancy, spontaneous menses, or cyclic progestin therapy.
The bottom line
PCOS is a metabolic condition dressed up as a reproductive one. Understanding the insulin resistance link changes how you think about treatment. Every intervention that improves insulin sensitivity, from weight loss to metformin to inositol, tends to improve PCOS symptoms broadly, not just the metabolic ones.
If you have PCOS and have never had insulin resistance assessed, ask your physician for a fasting insulin and HOMA-IR at your next visit. This single data point often reshapes the treatment plan.